TERF2 and liver cancer: Strikingly, although HULC plus MALAT1 enhances TRF2 transcriptional activity via CREPT, CREPT overexpression could not promote growth of liver cancer stem cell after both HULC and MALAT1 were knocked down in liver cancer stem cells.